Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Both [68Ga]Ga-FAPI and [18F]FDG PET/CT missed bone metastasis in a patient with breast cancer.

Literature DB >> 34131802

Both [⁶⁸Ga]Ga-FAPI and [¹⁸F]FDG PET/CT missed bone metastasis in a patient with breast cancer.

Shan Zheng¹, Yun Chen¹, Youzhi Zhu², Shaobo Yao^3,4, Weibing Miao^5,6.

Abstract

Entities: Disease Species

Year: 2021 PMID： 34131802 DOI： 10.1007/s00259-021-05453-6

Source DB: PubMed Journal: Eur J Nucl Med Mol Imaging ISSN： 1619-7070 Impact factor: 9.236

× No keyword cloud information.

4 in total

1. Usefulness of [⁶⁸Ga]Ga-DOTA-FAPI-04 PET/CT in patients presenting with inconclusive [¹⁸F]FDG PET/CT findings.

Authors: Haojun Chen; Liang Zhao; Dan Ruan; Yizhen Pang; Bing Hao; Yaqing Dai; Xiurong Wu; Wei Guo; Chunlei Fan; Jingxun Wu; Weipeng Huang; Qin Lin; Long Sun; Hua Wu
Journal: Eur J Nucl Med Mol Imaging Date: 2020-06-25 Impact factor: 9.236

2. Comparison of [⁶⁸Ga]Ga-DOTA-FAPI-04 and [¹⁸F] FDG PET/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer.

Authors: Haojun Chen; Yizhen Pang; Jingxun Wu; Liang Zhao; Bing Hao; Jing Wu; Jihong Wei; Siming Wu; Long Zhao; Zuoming Luo; Xuehua Lin; Chengrong Xie; Long Sun; Qin Lin; Hua Wu
Journal: Eur J Nucl Med Mol Imaging Date: 2020-03-28 Impact factor: 9.236

3. Progressive osteoblastic bone metastases in breast cancer negative on FDG-PET.

Authors: Valérie Huyge; Camilo Garcia; Anja Vanderstappen; Jean Alexiou; Thierry Gil; Patrick Flamen
Journal: Clin Nucl Med Date: 2009-07 Impact factor: 7.794

4. Bone metastases from breast cancer: associations between morphologic CT patterns and glycolytic activity on PET and bone scintigraphy as well as explorative search for influential factors.

Authors: Tsutomu Sugihara; Mitsuru Koizumi; Masamichi Koyama; Takashi Terauchi; Naoya Gomi; Yoshinori Ito; Kiyohiko Hatake; Naohiro Sata
Journal: Ann Nucl Med Date: 2017-09-01 Impact factor: 2.668

4 in total

1 in total

Review 1. Clinical summary of fibroblast activation protein inhibitor-based radiopharmaceuticals: cancer and beyond.

Authors: Mengting Li; Muhsin H Younis; Yongxue Zhang; Weibo Cai; Xiaoli Lan
Journal: Eur J Nucl Med Mol Imaging Date: 2022-01-31 Impact factor: 10.057